Sumatriptan succinate and Copaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Copaxone (glatiramer acetate). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Copaxone. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

On Jul, 11, 2026

43 people who take Sumatriptan succinate and Copaxone together, and have interactions are studied.

Sumatriptan succinate and Copaxone drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Copaxone, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Drug ineffective
Pain
Sleep disorder
Weight increased
Fatigue (feeling of tiredness)
Gait disturbance
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Insomnia (sleeplessness)
Memory impairment

male:

n/a

What are the common drug interactions of Sumatriptan Succinate and Copaxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaphylactic reaction (serious allergic reaction)

30-39:

Injection site erythema (redness at injection site)
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site rash
Injection site swelling
Nausea (feeling of having an urge to vomit)
Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Back pain
Cough
Dental caries
Drug ineffective
Dry mouth
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Memory impairment

50-59:

Nausea (feeling of having an urge to vomit)
Anxiety
Diarrhoea
Hypopnoea (decrease in the breathing rate)
Ocular icterus (presence of jaundice seen in the sclera of the eye)
Renal injury (kidney injury)
Unresponsive to stimuli
Yellow skin
Drug ineffective
Gait disturbance

60+:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Constipation
Depressed mood
Drug ineffective
Drug intolerance (drug sensitivity)
Fatigue (feeling of tiredness)
Feeling cold
Hordeolum (small collection of pus (abscess) on the eyelid)
Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

Pain: 9 people, 20.93%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 20.93%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 16.28%
Stress And Anxiety: 3 people, 6.98%
Gait Disturbance: 3 people, 6.98%
Drowsiness: 3 people, 6.98%
Depression: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Copaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously